Cel-Sci Corp.. (CVM) NYSE MKT LLC
$2.43 0.02 (0.83%)
Market Cap: $108.66M
As of 06/02/23 04:00 PM EDT. Market closed.

Cel-Sci Corp.. (CVM)
NYSE MKT LLC
$2.43
0.02 (0.83%)
Market Cap: $108.66M
As of 06/02/23 04:00 PM EDT. Market closed.
CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients who are newly diagnosed with advanced primary squamous cell carcinoma of the head and neck, are treated with the investigational product Multikine first, BEFORE they received surgery, radiation and/or ... read more
CEL-SCI believes that boosting a patient’s immune system while it is still intact should provide the greatest possible impact on survival. Therefore, in the Phase 3 study CEL-SCI treated patients who are newly diagnosed with advanced primary squamous cell carcinoma of the head and neck, are treated with the investigational product Multikine first, BEFORE they received surgery, radiation and/or chemotherapy (the current standard of care for these patients). This approach is unique. Most other cancer immunotherapies are administered only after conventional therapies have been tried and/or failed. Multikine (Leukocyte Interleukin, Injection), has received Orphan Drug designation from the FDA for the neoadjuvant therapy in patients with squamous cell carcinoma (cancer) of the head and neck. CEL-SCI believes that this Phase 3 study is the largest Phase 3 study in the world for the treatment of head and neck cancer. Per the study’s protocol, newly diagnosed patients with advanced primary squamous cell carcinoma of the head and neck were treated with the Multikine treatment regimen right after diagnosis and prior to receiving the Standard of Care (SOC), which involves surgery, radiation or concurrent radiochemotherapy. Multikine is designed to help the immune system “see” the tumor at a time when the immune system is still relatively intact and thereby thought to better be able to mount an attack on the tumor. The aim of treatment with Multikine is to boost the body’s immune system prior to SOC to attack the cancer. The Phase 3 study is fully enrolled with 928 patients and the last patient was treated in September 2016. To prove an overall survival benefit, the study requires CEL-SCI to wait until 298 (death) events have occurred among the two main comparator groups. This study milestone occurred in late April 2020. The study is currently in the statistical analysis phase. The Company’s LEAPS technology is being developed for rheumatoid arthritis and as a potential treatment for COVID-19 infection. The Company has operations in Vienna, Virginia, and near/in Baltimore, Maryland. read less
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2023 | Option Exercise | $2.32 | 1,034 | 2,399 | 109,211 | Apr 06, 2023, 04:22 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2023 | Option Exercise | $2.32 | 1,849 | 4,290 | 215,291 | Apr 06, 2023, 04:19 PM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2023 | Option Exercise | $2.32 | 2,133 | 4,949 | 1,154,768 | Apr 06, 2023, 04:15 PM |
TALOR EYAL | Chief Scientific Officer | Dec 30, 2022 | Option Exercise | $2.35 | 1,021 | 2,399 | 108,177 | Jan 03, 2023, 09:52 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 30, 2022 | Option Exercise | $2.35 | 1,825 | 4,289 | 213,442 | Jan 03, 2023, 09:49 AM |
KERSTEN GEERT R | Chief Executive Officer | Dec 30, 2022 | Option Exercise | $2.35 | 1,851 | 4,350 | 1,152,635 | Jan 03, 2023, 09:46 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2022 | Option Exercise | $3.09 | 1,266 | 3,912 | 120,226 | Oct 03, 2022, 07:23 AM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2022 | Option Exercise | $3.09 | 776 | 2,398 | 107,156 | Oct 03, 2022, 07:21 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2022 | Option Exercise | $3.09 | 1,388 | 4,289 | 211,617 | Oct 03, 2022, 07:18 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2022 | Option Exercise | $3.09 | 1,407 | 4,348 | 1,150,784 | Oct 03, 2022, 07:15 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 30, 2022 | Option Exercise | $4.50 | 876 | 3,942 | 118,960 | Jul 05, 2022, 09:22 AM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2022 | Option Exercise | $4.50 | 533 | 2,399 | 106,380 | Jul 05, 2022, 09:20 AM |
PRICHEP PATRICIA B | Senior Vice President | Jun 30, 2022 | Option Exercise | $4.50 | 953 | 4,289 | 210,229 | Jul 05, 2022, 09:17 AM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2022 | Option Exercise | $4.50 | 966 | 4,347 | 1,149,377 | Jul 05, 2022, 09:14 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2022 | Option Exercise | $3.93 | 1,006 | 3,954 | 118,084 | Mar 31, 2022, 04:56 PM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2022 | Option Exercise | $3.93 | 610 | 2,397 | 105,847 | Mar 31, 2022, 04:54 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2022 | Option Exercise | $3.93 | 1,091 | 4,288 | 209,276 | Mar 31, 2022, 04:52 PM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2022 | Option Exercise | $3.93 | 1,106 | 4,347 | 1,148,411 | Mar 31, 2022, 04:49 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2021 | Option Exercise | $7.10 | 557 | 3,955 | 117,078 | Jan 03, 2022, 10:14 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2021 | Option Exercise | $7.10 | 338 | 2,400 | 105,237 | Jan 03, 2022, 10:11 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2021 | Option Exercise | $7.10 | 604 | 4,288 | 208,185 | Jan 03, 2022, 10:07 AM |
KERSTEN GEERT R | Chief Executive Officer | Dec 31, 2021 | Option Exercise | $7.10 | 612 | 4,345 | 1,147,305 | Jan 03, 2022, 10:04 AM |
TALOR EYAL | Chief Scientific Officer | Oct 19, 2021 | Sale | $11.25 | 15,000 | 168,750 | 104,899 | Oct 21, 2021, 05:24 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2021 | Option Exercise | $10.99 | 343 | 3,770 | 116,521 | Oct 04, 2021, 09:13 AM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2021 | Option Exercise | $10.99 | 218 | 2,396 | 119,899 | Oct 04, 2021, 09:11 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2021 | Option Exercise | $10.99 | 372 | 4,088 | 207,581 | Oct 04, 2021, 09:09 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2021 | Option Exercise | $10.99 | 395 | 4,341 | 1,146,693 | Oct 04, 2021, 09:07 AM |
Watson Robert Eugene | Director | Jul 06, 2021 | Buy | $8.00 | 1,250 | 10,000 | 4,431 | Jul 07, 2021, 10:51 AM |
BAILLAVOINE BRUNO JEAN-MARIE | Director | Jul 06, 2021 | Buy | $8.00 | 1,250 | 10,000 | 5,973 | Jul 07, 2021, 10:48 AM |
KERSTEN GEERT R | Chief Executive Officer | Jul 06, 2021 | Buy | $8.00 | 25,000 | 200,000 | 1,146,298 | Jul 07, 2021, 10:44 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 30, 2021 | Option Exercise | $8.68 | 435 | 3,776 | 116,178 | Jul 01, 2021, 09:12 AM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2021 | Option Exercise | $8.68 | 276 | 2,396 | 119,681 | Jul 01, 2021, 09:08 AM |
PRICHEP PATRICIA B | Senior Vice President | Jun 30, 2021 | Option Exercise | $8.68 | 471 | 4,088 | 207,209 | Jul 01, 2021, 09:05 AM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2021 | Option Exercise | $8.68 | 501 | 4,349 | 1,121,298 | Jul 01, 2021, 09:02 AM |
CIPRIANO JOHN | Senior Vice President | Apr 22, 2021 | Sale | $24.38 | 10,000 | 243,793 | 63,108 | Apr 23, 2021, 05:16 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2021 | Option Exercise | $15.21 | 248 | 3,772 | 115,743 | Apr 01, 2021, 10:13 AM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2021 | Option Exercise | $15.21 | 157 | 2,388 | 119,405 | Apr 01, 2021, 10:09 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2021 | Option Exercise | $15.21 | 269 | 4,091 | 206,738 | Apr 01, 2021, 10:06 AM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2021 | Option Exercise | $15.21 | 285 | 4,335 | 1,120,797 | Apr 01, 2021, 10:03 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2020 | Option Exercise | $11.66 | 309 | 3,603 | 115,495 | Jan 04, 2021, 09:11 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2020 | Option Exercise | $11.66 | 205 | 2,390 | 119,248 | Jan 04, 2021, 09:08 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2020 | Option Exercise | $11.66 | 335 | 3,906 | 206,469 | Jan 04, 2021, 09:06 AM |
KERSTEN GEERT R | Chief Executive Officer | Dec 31, 2020 | Option Exercise | $11.66 | 366 | 4,268 | 1,120,512 | Jan 04, 2021, 09:03 AM |
YOUNG PETER R | Director | Dec 11, 2020 | Buy | $14.24 | 100 | 1,424 | 25,914 | Dec 16, 2020, 09:16 AM |
YOUNG PETER R | Director | Nov 17, 2020 | Buy | $11.68 | 800 | 9,343 | 25,814 | Nov 18, 2020, 11:10 AM |
BAILLAVOINE BRUNO JEAN-MARIE | Director | Nov 18, 2020 | Buy | $11.77 | 800 | 9,416 | 4,723 | Nov 18, 2020, 10:45 AM |
Watson Robert Eugene | Director | Nov 18, 2020 | Buy | $11.77 | 800 | 9,416 | 3,181 | Nov 18, 2020, 09:59 AM |
CIPRIANO JOHN | Senior Vice President | Nov 13, 2020 | Sale | $12.73 | 10,000 | 127,290 | 73,108 | Nov 16, 2020, 04:49 PM |
YOUNG PETER R | Director | Nov 04, 2020 | Buy | $11.34 | 2,000 | 22,670 | 25,014 | Nov 06, 2020, 04:26 PM |
YOUNG PETER R | Director | Nov 04, 2020 | Buy | $11.39 | 1,000 | 11,390 | 23,014 | Nov 06, 2020, 04:26 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2020 | Option Exercise | $12.75 | 275 | 3,506 | 115,186 | Oct 01, 2020, 09:40 AM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2020 | Option Exercise | $12.75 | 188 | 2,397 | 119,043 | Oct 01, 2020, 09:37 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2020 | Option Exercise | $12.75 | 297 | 3,787 | 206,134 | Oct 01, 2020, 09:33 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2020 | Option Exercise | $12.75 | 335 | 4,271 | 1,120,146 | Oct 01, 2020, 09:30 AM |
ZIMMERMAN DANIEL H | Senior VP, Research | Jun 30, 2020 | Option Exercise | $14.92 | 228 | 3,402 | 114,911 | Jul 01, 2020, 10:40 AM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2020 | Option Exercise | $14.92 | 160 | 2,387 | 118,855 | Jul 01, 2020, 10:36 AM |
PRICHEP PATRICIA B | Senior VP, Operations | Jun 30, 2020 | Option Exercise | $14.92 | 245 | 3,655 | 205,837 | Jul 01, 2020, 10:33 AM |
KERSTEN GEERT R | CEO | Jun 30, 2020 | Option Exercise | $14.92 | 286 | 4,267 | 1,119,811 | Jul 01, 2020, 10:28 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2020 | Option Exercise | $11.54 | 296 | 3,416 | 114,683 | Apr 01, 2020, 09:11 AM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2020 | Option Exercise | $11.54 | 207 | 2,389 | 118,695 | Apr 01, 2020, 09:09 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2020 | Option Exercise | $11.54 | 317 | 3,658 | 205,592 | Apr 01, 2020, 09:07 AM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2020 | Option Exercise | $11.54 | 370 | 4,270 | 1,119,525 | Apr 01, 2020, 09:04 AM |
Watson Robert Eugene | Director | Feb 26, 2020 | Buy | $10.83 | 923 | 9,996 | 2,381 | Feb 27, 2020, 07:57 AM |
BAILLAVOINE BRUNO JEAN-MARIE | Director | Feb 26, 2020 | Buy | $10.83 | 923 | 9,996 | 3,923 | Feb 27, 2020, 07:53 AM |
YOUNG PETER R | Director | Feb 26, 2020 | Buy | $10.83 | 923 | 9,996 | 22,014 | Feb 27, 2020, 07:49 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Feb 26, 2020 | Buy | $10.83 | 923 | 9,996 | 114,387 | Feb 27, 2020, 07:45 AM |
PRICHEP PATRICIA B | Senior Vice President | Feb 26, 2020 | Buy | $10.83 | 1,847 | 20,003 | 205,275 | Feb 27, 2020, 07:37 AM |
KERSTEN GEERT R | Chief Executive Officer | Feb 26, 2020 | Buy | $10.83 | 4,617 | 50,002 | 1,119,155 | Feb 27, 2020, 07:33 AM |
KERSTEN GEERT R | Chief Executive Officer | Jan 10, 2020 | Buy | $7.54 | 6,631 | 49,998 | 1,114,538 | Jan 13, 2020, 08:10 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2019 | Option Exercise | $9.15 | 373 | 3,413 | 113,464 | Jan 03, 2020, 10:36 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2019 | Option Exercise | $9.15 | 262 | 2,397 | 118,488 | Jan 03, 2020, 10:33 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2019 | Option Exercise | $9.15 | 401 | 3,669 | 203,428 | Jan 03, 2020, 10:31 AM |
KERSTEN GEERT R | Chief Executive Officer | Dec 31, 2019 | Option Exercise | $9.15 | 483 | 4,419 | 1,107,907 | Jan 03, 2020, 10:28 AM |
KERSTEN GEERT R | Chief Executive Officer | Oct 25, 2019 | Buy | $6.71 | 3,725 | 24,995 | 1,107,424 | Oct 28, 2019, 06:32 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2019 | Option Exercise | $8.94 | 382 | 3,415 | 113,091 | Oct 01, 2019, 04:44 PM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2019 | Option Exercise | $8.94 | 268 | 2,396 | 118,226 | Oct 01, 2019, 04:41 PM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2019 | Option Exercise | $8.94 | 410 | 3,665 | 203,027 | Oct 01, 2019, 04:37 PM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2019 | Option Exercise | $8.94 | 461 | 4,121 | 1,103,699 | Oct 01, 2019, 04:34 PM |
CIPRIANO JOHN | Senior Vice President | Sep 17, 2019 | Sale | $8.69 | 8,000 | 69,559 | 83,108 | Sep 18, 2019, 05:02 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 04, 2019 | Option Exercise | $7.16 | 2,375 | 17,005 | 112,302 | Sep 05, 2019, 08:00 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 04, 2019 | Option Exercise | $7.16 | 2,095 | 15,000 | 202,180 | Sep 05, 2019, 07:57 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 04, 2019 | Option Exercise | $7.16 | 3,492 | 25,003 | 1,102,746 | Sep 05, 2019, 07:54 AM |
CIPRIANO JOHN | Senior Vice President | Aug 28, 2019 | Sale | $7.03 | 8,000 | 56,208 | 91,108 | Aug 29, 2019, 05:14 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 03, 2019 | Option Exercise | $3.77 | 6,631 | 24,999 | 1,099,254 | Jun 03, 2019, 09:03 PM |
YOUNG PETER R | Director | May 21, 2019 | Buy | $5.00 | 2,000 | 10,000 | 21,091 | May 21, 2019, 09:18 PM |
Watson Robert Eugene | Director | May 07, 2019 | Option Exercise | $6.86 | 1,458 | 10,002 | 1,458 | May 08, 2019, 08:12 AM |
ZIMMERMAN DANIEL H | Senior Vice President | May 07, 2019 | Option Exercise | $6.86 | 4,373 | 29,999 | 109,927 | May 08, 2019, 08:09 AM |
CIPRIANO JOHN | Senior Vice President | May 07, 2019 | Option Exercise | $6.86 | 2,915 | 19,997 | 99,108 | May 08, 2019, 08:06 AM |
PRICHEP PATRICIA B | Senior Vice President | May 07, 2019 | Option Exercise | $6.86 | 7,289 | 50,003 | 200,085 | May 08, 2019, 08:03 AM |
KERSTEN GEERT R | Chief Executive Officer | May 07, 2019 | Option Exercise | $6.86 | 14,577 | 99,998 | 1,092,623 | May 08, 2019, 08:00 AM |
YOUNG PETER R | Director | Apr 05, 2019 | Buy | $5.20 | 2,000 | 10,400 | 19,091 | Apr 09, 2019, 04:51 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 29, 2019 | Option Exercise | $3.54 | 965 | 3,416 | 105,554 | Apr 01, 2019, 11:55 AM |
TALOR EYAL | Chief Scientific Officer | Mar 29, 2019 | Option Exercise | $3.54 | 677 | 2,397 | 117,672 | Apr 01, 2019, 11:51 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 29, 2019 | Option Exercise | $3.54 | 1,036 | 3,667 | 192,796 | Apr 01, 2019, 11:49 AM |
KERSTEN GEERT R | Chief Executive Officer | Mar 29, 2019 | Option Exercise | $3.54 | 1,165 | 4,124 | 1,078,046 | Apr 01, 2019, 11:45 AM |
YOUNG PETER R | Director | Feb 14, 2019 | Buy | $2.82 | 1,000 | 2,820 | 17,091 | Feb 19, 2019, 10:56 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2018 | Option Exercise | $2.87 | 836 | 2,399 | 116,995 | Jan 02, 2019, 05:07 PM |
PRICHEP PATRICIA B | Sr. Vice President | Dec 31, 2018 | Option Exercise | $2.87 | 1,278 | 3,668 | 191,760 | Jan 02, 2019, 04:59 PM |
ZIMMERMAN DANIEL H | Sr. Vice President | Dec 31, 2018 | Option Exercise | $2.87 | 1,190 | 3,415 | 107,063 | Jan 02, 2019, 04:53 PM |
ZIMMERMAN DANIEL H | Sr. Vice President | Dec 31, 2018 | Sale | $2.93 | 2,474 | 7,249 | 104,589 | Jan 02, 2019, 04:53 PM |
KERSTEN GEERT R | CEO | Dec 31, 2018 | Option Exercise | $2.87 | 1,437 | 4,124 | 1,076,881 | Jan 02, 2019, 04:24 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 28, 2018 | Option Exercise | $4.05 | 843 | 3,414 | 105,873 | Oct 01, 2018, 10:44 AM |
TALOR EYAL | Chief Scientific Officer | Sep 28, 2018 | Option Exercise | $4.05 | 592 | 2,398 | 116,159 | Oct 01, 2018, 10:40 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 28, 2018 | Option Exercise | $4.05 | 906 | 3,669 | 190,482 | Oct 01, 2018, 10:38 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 28, 2018 | Option Exercise | $4.05 | 1,018 | 4,123 | 1,075,444 | Oct 01, 2018, 10:35 AM |
CIPRIANO JOHN | Senior Vice President | Aug 13, 2018 | Option Exercise | $0.83 | 48,193 | 40,000 | 96,193 | Aug 15, 2018, 02:22 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Aug 13, 2018 | Option Exercise | $0.83 | 84,337 | 70,000 | 105,030 | Aug 15, 2018, 02:19 PM |
PRICHEP PATRICIA B | Senior Vice President | Aug 13, 2018 | Option Exercise | $0.83 | 30,120 | 25,000 | 189,576 | Aug 15, 2018, 02:17 PM |
KERSTEN GEERT R | Chief Executive Officer | Aug 13, 2018 | Option Exercise | $0.83 | 301,205 | 250,000 | 1,074,426 | Aug 14, 2018, 01:04 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 29, 2018 | Option Exercise | $0.92 | 3,713 | 3,416 | 20,693 | Jul 02, 2018, 11:04 AM |
TALOR EYAL | Chief Scientific Officer | Jun 29, 2018 | Option Exercise | $0.92 | 2,608 | 2,399 | 115,567 | Jul 02, 2018, 11:01 AM |
PRICHEP PATRICIA B | Senior Vice President | Jun 29, 2018 | Option Exercise | $0.92 | 3,988 | 3,669 | 159,456 | Jul 02, 2018, 10:58 AM |
KERSTEN GEERT R | Chief Executive Officer | Jun 29, 2018 | Option Exercise | $0.92 | 4,483 | 4,124 | 773,221 | Jul 02, 2018, 10:55 AM |
PRICHEP PATRICIA B | Senior Vice President | Jun 11, 2018 | Option Exercise | $2.80 | 315 | 882 | 155,468 | Jun 18, 2018, 01:07 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 11, 2018 | Option Exercise | $2.80 | 3,151 | 8,823 | 768,738 | Jun 18, 2018, 01:03 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 11, 2018 | Option Exercise | $2.80 | 3,464 | 9,699 | 765,587 | Jun 18, 2018, 01:03 PM |
PRICHEP PATRICIA B | Sr. V.P. Operations | Jun 11, 2018 | Option Exercise | $2.29 | 10,917 | 25,000 | 155,153 | Jun 13, 2018, 11:22 AM |
KERSTEN GEERT R | CEO | Jun 11, 2018 | Option Exercise | $2.29 | 109,170 | 249,999 | 762,123 | Jun 13, 2018, 11:04 AM |
KERSTEN GEERT R | CEO | Jun 11, 2018 | Option Exercise | $1.69 | 147,929 | 250,000 | 652,953 | Jun 13, 2018, 11:04 AM |
YOUNG PETER R | Director | Jun 04, 2018 | Option Exercise | $1.75 | 2,400 | 4,200 | 16,091 | Jun 08, 2018, 01:54 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 01, 2018 | Option Exercise | $1.75 | 14,760 | 25,830 | 505,024 | Jun 05, 2018, 01:36 PM |
YOUNG PETER R | Director | May 01, 2018 | Buy | $2.14 | 2,000 | 4,280 | 13,691 | May 03, 2018, 08:48 AM |
YOUNG PETER R | Director | Apr 27, 2018 | Buy | $2.38 | 4,000 | 9,540 | 11,691 | May 01, 2018, 09:21 AM |
YOUNG PETER R | Director | Apr 16, 2018 | Buy | $1.80 | 6,500 | 11,675 | 7,691 | Apr 17, 2018, 12:42 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 30, 2018 | Option Exercise | $1.41 | 2,422 | 3,415 | 16,980 | Apr 03, 2018, 10:00 AM |
TALOR EYAL | Chief Scientific Officer | Mar 30, 2018 | Option Exercise | $1.41 | 1,702 | 2,400 | 112,959 | Apr 03, 2018, 09:57 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 30, 2018 | Option Exercise | $1.41 | 2,602 | 3,669 | 144,236 | Apr 03, 2018, 09:53 AM |
KERSTEN GEERT R | Chief Executive Officer | Mar 30, 2018 | Option Exercise | $1.41 | 2,925 | 4,124 | 490,264 | Apr 03, 2018, 09:50 AM |
TALOR EYAL | CSO | Jan 17, 2018 | Sale | $2.06 | 1,751 | 3,607 | 117,698 | Jan 22, 2018, 04:47 PM |
TALOR EYAL | CSO | Jan 22, 2018 | Sale | $2.06 | 6,441 | 13,268 | 111,257 | Jan 22, 2018, 04:47 PM |
TALOR EYAL | CSO | Jan 16, 2018 | Sale | $2.15 | 1,707 | 3,670 | 119,449 | Jan 18, 2018, 05:05 PM |
TALOR EYAL | CSO | Jan 12, 2018 | Sale | $2.15 | 101 | 217 | 121,156 | Jan 18, 2018, 05:05 PM |
ZIMMERMAN DANIEL H | Sr. Vice President | Dec 29, 2017 | Option Exercise | $1.89 | 1,807 | 3,415 | 14,558 | Jan 03, 2018, 10:19 AM |
TALOR EYAL | Chief Scientific Officer | Dec 29, 2017 | Option Exercise | $1.89 | 1,269 | 2,398 | 121,257 | Jan 03, 2018, 10:14 AM |
PRICHEP PATRICIA B | Sr. V.P. Operatioms | Dec 29, 2017 | Option Exercise | $1.89 | 1,941 | 3,668 | 141,634 | Jan 03, 2018, 10:08 AM |
KERSTEN GEERT R | Chief Executive Officer | Dec 29, 2017 | Option Exercise | $1.89 | 2,103 | 3,975 | 487,339 | Jan 03, 2018, 10:02 AM |
ZIMMERMAN DANIEL H | Sr. Vice President | Sep 29, 2017 | Option Exercise | $1.66 | 2,058 | 3,416 | 12,751 | Oct 02, 2017, 10:31 AM |
TALOR EYAL | Chief Scientific Officer | Sep 29, 2017 | Option Exercise | $1.66 | 1,445 | 2,399 | 119,988 | Oct 02, 2017, 10:08 AM |
PRICHEP PATRICIA B | Sr. V.P. Operatioms | Sep 29, 2017 | Option Exercise | $1.66 | 2,210 | 3,669 | 139,693 | Oct 02, 2017, 10:02 AM |
KERSTEN GEERT R | CEO | Sep 29, 2017 | Option Exercise | $1.66 | 2,394 | 3,974 | 485,236 | Oct 02, 2017, 09:56 AM |
TALOR EYAL | Chief Scientific Officer | Aug 25, 2017 | Sale | $1.91 | 769 | 1,469 | 118,543 | Aug 29, 2017, 05:19 PM |
CIPRIANO JOHN | Senior Vice President | Aug 16, 2017 | Sale | $2.52 | 17,109 | 43,115 | 48,000 | Aug 17, 2017, 05:25 PM |
TALOR EYAL | Chief Scientific Officer | Aug 16, 2017 | Sale | $2.58 | 12,000 | 30,960 | 119,312 | Aug 17, 2017, 05:20 PM |
TALOR EYAL | Chief Scientific Officer | Aug 15, 2017 | Sale | $2.82 | 2,019 | 5,694 | 131,312 | Aug 17, 2017, 05:20 PM |
ZIMMERMAN DANIEL H | Sr. Vice President | Jun 30, 2017 | Option Exercise | $2.23 | 1,532 | 3,416 | 10,693 | Jul 05, 2017, 10:39 AM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2017 | Option Exercise | $2.23 | 1,076 | 2,399 | 133,331 | Jul 05, 2017, 10:21 AM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2017 | Option Exercise | $2.23 | 1,782 | 3,974 | 482,842 | Jul 05, 2017, 10:12 AM |
PRICHEP PATRICIA B | Sr. Vice President | Jun 30, 2017 | Option Exercise | $2.23 | 1,645 | 3,668 | 137,483 | Jul 05, 2017, 10:07 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2017 | Option Exercise | $0.09 | 39,911 | 3,416 | 229,023 | Apr 04, 2017, 10:10 AM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2017 | Option Exercise | $0.09 | 28,037 | 2,400 | 3,306,368 | Apr 04, 2017, 10:06 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2017 | Option Exercise | $0.09 | 42,869 | 3,670 | 3,395,947 | Apr 04, 2017, 10:02 AM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2017 | Option Exercise | $0.09 | 46,436 | 3,975 | 12,026,505 | Apr 04, 2017, 09:59 AM |
ZIMMERMAN DANIEL H | Sr. Vice President | Dec 30, 2016 | Option Exercise | $0.07 | 46,026 | 3,084 | 189,112 | Jan 03, 2017, 10:46 AM |
TALOR EYAL | Chief Scientific Officer | Dec 30, 2016 | Option Exercise | $0.07 | 35,820 | 2,400 | 3,278,331 | Jan 03, 2017, 10:30 AM |
PRICHEP PATRICIA B | Sr. Vice President | Dec 30, 2016 | Option Exercise | $0.07 | 50,206 | 3,364 | 3,353,078 | Jan 03, 2017, 10:13 AM |
KERSTEN GEERT R | CEO | Dec 30, 2016 | Option Exercise | $0.07 | 59,328 | 3,975 | 11,980,069 | Jan 03, 2017, 10:07 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2016 | Option Exercise | $0.30 | 11,388 | 3,416 | 143,086 | Oct 03, 2016, 01:14 PM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2016 | Option Exercise | $0.30 | 8,000 | 2,400 | 3,242,511 | Oct 03, 2016, 01:11 PM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2016 | Option Exercise | $0.30 | 12,232 | 3,670 | 3,302,872 | Oct 03, 2016, 01:08 PM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2016 | Option Exercise | $0.30 | 13,250 | 3,975 | 11,920,741 | Oct 03, 2016, 01:06 PM |
DE CLARA MAXIMILIAN | Former Officer and Director | Aug 31, 2016 | Option Exercise | $0.47 | 650,000 | 305,500 | 675,123 | Sep 23, 2016, 05:10 PM |
ZIMMERMAN DANIEL H | Sr. Vice President | Jul 13, 2016 | Option Exercise | $0.47 | 14,154 | 6,652 | 131,698 | Jul 19, 2016, 03:25 PM |
CIPRIANO JOHN | Sr. Vice President | Jul 13, 2016 | Option Exercise | $0.47 | 13,100 | 6,157 | 1,627,718 | Jul 19, 2016, 03:20 PM |
TALOR EYAL | Chief Scientific Officer | Jul 13, 2016 | Option Exercise | $0.47 | 18,805 | 8,838 | 3,234,511 | Jul 19, 2016, 03:15 PM |
PRICHEP PATRICIA B | Sr. Vice President | Jul 13, 2016 | Option Exercise | $0.47 | 15,232 | 7,159 | 3,290,640 | Jul 19, 2016, 03:10 PM |
KERSTEN GEERT R | Chief Executive Officer | Jul 13, 2016 | Option Exercise | $0.47 | 34,644 | 16,283 | 11,907,491 | Jul 19, 2016, 03:03 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 30, 2016 | Option Exercise | $0.46 | 7,426 | 3,416 | 117,544 | Jun 30, 2016, 04:49 PM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2016 | Option Exercise | $0.46 | 5,217 | 2,400 | 3,215,706 | Jun 30, 2016, 04:47 PM |
PRICHEP PATRICIA B | Senior Vice President | Jun 30, 2016 | Option Exercise | $0.46 | 7,977 | 3,669 | 3,275,408 | Jun 30, 2016, 04:44 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2016 | Option Exercise | $0.46 | 8,641 | 3,975 | 11,872,847 | Jun 30, 2016, 04:41 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2016 | Option Exercise | $0.53 | 6,446 | 3,416 | 110,118 | Apr 05, 2016, 05:00 PM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2016 | Option Exercise | $0.53 | 4,528 | 2,400 | 3,210,489 | Apr 05, 2016, 04:57 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2016 | Option Exercise | $0.53 | 6,923 | 3,669 | 3,267,431 | Apr 05, 2016, 04:55 PM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2016 | Option Exercise | $0.53 | 7,500 | 3,975 | 11,864,206 | Apr 05, 2016, 04:52 PM |
KERSTEN GEERT R | Chief Executive Officer | Jan 13, 2016 | Option Exercise | $0.37 | 3,000,000 | 1,110,000 | 11,856,706 | Jan 14, 2016, 08:49 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2015 | Option Exercise | $0.37 | 9,348 | 3,459 | 103,672 | Jan 05, 2016, 11:16 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2015 | Option Exercise | $0.37 | 6,486 | 2,400 | 3,205,541 | Jan 05, 2016, 11:13 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2015 | Option Exercise | $0.37 | 10,042 | 3,716 | 3,260,508 | Jan 05, 2016, 11:11 AM |
KERSTEN GEERT R | Chief Executive | Dec 31, 2015 | Option Exercise | $0.37 | 10,743 | 3,975 | 8,856,706 | Jan 05, 2016, 11:08 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2015 | Option Exercise | $0.60 | 5,480 | 3,288 | 94,324 | Sep 30, 2015, 04:42 PM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2015 | Option Exercise | $0.60 | 4,000 | 2,400 | 3,199,055 | Sep 30, 2015, 04:39 PM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2015 | Option Exercise | $0.60 | 5,886 | 3,532 | 3,250,466 | Sep 30, 2015, 04:37 PM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2015 | Option Exercise | $0.60 | 6,625 | 3,975 | 8,845,963 | Sep 30, 2015, 04:34 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Jul 27, 2015 | Option Exercise | $0.54 | 15,794 | 8,529 | 88,844 | Jul 28, 2015, 05:03 PM |
CIPRIANO JOHN | Senior Vice President | Jul 27, 2015 | Option Exercise | $0.54 | 14,618 | 7,894 | 1,614,618 | Jul 28, 2015, 05:00 PM |
TALOR EYAL | Chief Scientific Officer | Jul 27, 2015 | Option Exercise | $0.54 | 20,983 | 11,331 | 3,195,055 | Jul 28, 2015, 04:57 PM |
PRICHEP PATRICIA B | Senior Vice President | Jul 27, 2015 | Option Exercise | $0.54 | 16,997 | 9,178 | 3,244,580 | Jul 28, 2015, 04:54 PM |
KERSTEN GEERT R | Chief Executive Officer | Jul 27, 2015 | Option Exercise | $0.54 | 38,658 | 20,875 | 8,839,338 | Jul 28, 2015, 04:51 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2015 | Option Exercise | $0.66 | 6,022 | 3,975 | 8,800,680 | Jul 01, 2015, 05:31 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 30, 2015 | Option Exercise | $0.66 | 4,982 | 3,288 | 73,050 | Jul 01, 2015, 05:11 PM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2015 | Option Exercise | $0.66 | 3,636 | 2,400 | 3,174,072 | Jul 01, 2015, 05:07 PM |
PRICHEP PATRICIA B | Senior Vice President | Jun 30, 2015 | Option Exercise | $0.66 | 5,351 | 3,532 | 3,227,583 | Jul 01, 2015, 05:03 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2015 | Option Exercise | $1.05 | 3,131 | 3,288 | 68,068 | Apr 13, 2015, 05:17 PM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2015 | Option Exercise | $1.05 | 2,285 | 2,399 | 3,170,436 | Apr 13, 2015, 05:13 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2015 | Option Exercise | $1.05 | 3,363 | 3,531 | 3,222,232 | Apr 13, 2015, 05:10 PM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2015 | Option Exercise | $1.05 | 4,071 | 4,275 | 8,794,658 | Apr 13, 2015, 05:06 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2014 | Option Exercise | $0.58 | 5,669 | 3,288 | 64,937 | Jan 09, 2015, 10:33 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2014 | Option Exercise | $0.58 | 4,137 | 2,399 | 3,168,151 | Jan 09, 2015, 10:28 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2014 | Option Exercise | $0.58 | 6,089 | 3,532 | 3,218,869 | Jan 09, 2015, 10:20 AM |
KERSTEN GEERT R | Chief Executive Officer | Dec 31, 2014 | Option Exercise | $0.58 | 6,594 | 3,825 | 8,790,587 | Jan 09, 2015, 10:17 AM |
KERSTEN GEERT R | Chief Executive Officer | Nov 04, 2014 | Option Exercise | $0.68 | 2,124,388 | 1,444,584 | 8,783,993 | Nov 07, 2014, 02:58 PM |
KERSTEN GEERT R | Chief Executive Officer | Oct 13, 2014 | Buy | $0.77 | 14,999 | 11,549 | 6,659,605 | Oct 14, 2014, 09:50 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2014 | Option Exercise | $0.91 | 3,681 | 3,350 | 59,268 | Oct 01, 2014, 03:53 PM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2014 | Option Exercise | $0.91 | 2,637 | 2,400 | 3,164,014 | Oct 01, 2014, 03:50 PM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2014 | Option Exercise | $0.91 | 3,954 | 3,598 | 3,212,780 | Oct 01, 2014, 03:46 PM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2014 | Option Exercise | $0.91 | 4,203 | 3,825 | 6,644,606 | Oct 01, 2014, 03:42 PM |
KERSTEN GEERT R | Chief Executive Officer | Aug 22, 2014 | Option Exercise | $0.01 | 103,093 | 1,031 | 6,640,403 | Aug 25, 2014, 12:49 PM |
CIPRIANO JOHN | Senior Vice President | Aug 06, 2014 | Option Exercise | $1.09 | 1,600,000 | 1,744,000 | 1,600,000 | Aug 07, 2014, 04:11 PM |
TALOR EYAL | Chief Scientific Officer | Aug 06, 2014 | Option Exercise | $1.09 | 3,100,000 | 3,379,000 | 3,161,377 | Aug 07, 2014, 04:04 PM |
PRICHEP PATRICIA B | Senior Vice President | Aug 06, 2014 | Option Exercise | $1.09 | 3,100,000 | 3,379,000 | 3,208,826 | Aug 07, 2014, 03:57 PM |
KERSTEN GEERT R | Chief Executive Officer | Aug 06, 2014 | Option Exercise | $1.09 | 5,800,000 | 6,322,000 | 6,537,310 | Aug 07, 2014, 03:49 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 30, 2014 | Option Exercise | $1.24 | 2,701 | 3,349 | 55,587 | Jul 01, 2014, 09:16 AM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2014 | Option Exercise | $1.24 | 1,935 | 2,399 | 61,377 | Jul 01, 2014, 09:12 AM |
PRICHEP PATRICIA B | Senior Vice President | Jun 30, 2014 | Option Exercise | $1.24 | 2,901 | 3,597 | 108,826 | Jul 01, 2014, 09:08 AM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2014 | Option Exercise | $1.24 | 3,084 | 3,824 | 737,310 | Jul 01, 2014, 09:05 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2014 | Option Exercise | $1.52 | 2,183 | 3,318 | 52,886 | Apr 02, 2014, 12:53 PM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2014 | Option Exercise | $1.52 | 1,578 | 2,399 | 59,442 | Apr 02, 2014, 12:51 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2014 | Option Exercise | $1.52 | 2,343 | 3,561 | 105,925 | Apr 02, 2014, 12:49 PM |
KERSTEN GEERT R | Chief Executive Officer | Mar 31, 2014 | Option Exercise | $1.52 | 2,516 | 3,824 | 734,226 | Apr 02, 2014, 12:47 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2013 | Option Exercise | $0.59 | 5,517 | 3,255 | 50,703 | Jan 06, 2014, 10:47 AM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2013 | Option Exercise | $0.59 | 4,067 | 2,400 | 57,864 | Jan 06, 2014, 10:44 AM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2013 | Option Exercise | $0.59 | 5,914 | 3,489 | 103,582 | Jan 06, 2014, 10:40 AM |
KERSTEN GEERT R | Chief Executive | Dec 31, 2013 | Option Exercise | $0.59 | 6,483 | 3,825 | 731,710 | Jan 06, 2014, 10:37 AM |
KERSTEN GEERT R | CEO | Dec 30, 2013 | Buy | $0.60 | 300,000 | 180,000 | 725,227 | Jan 02, 2014, 11:25 AM |
KERSTEN GEERT R | Chief Executive | Oct 09, 2013 | Buy | $0.79 | 8,400 | 6,632 | 425,227 | Oct 11, 2013, 10:00 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2013 | Option Exercise | $1.70 | 1,914 | 3,254 | 45,186 | Oct 04, 2013, 09:24 AM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2013 | Option Exercise | $1.70 | 1,411 | 2,399 | 53,797 | Oct 04, 2013, 09:22 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2013 | Option Exercise | $1.70 | 2,052 | 3,488 | 97,668 | Oct 04, 2013, 09:19 AM |
KERSTEN GEERT R | Chief Executive | Sep 30, 2013 | Option Exercise | $1.70 | 2,250 | 3,825 | 416,827 | Oct 04, 2013, 09:17 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 28, 2013 | Option Exercise | $0.21 | 15,502 | 3,255 | 432,719 | Jul 01, 2013, 04:24 PM |
TALOR EYAL | Chief Scientific Officer | Jun 28, 2013 | Option Exercise | $0.21 | 11,428 | 2,400 | 523,859 | Jul 01, 2013, 04:17 PM |
PRICHEP PATRICIA B | Senior Vice President | Jun 28, 2013 | Option Exercise | $0.21 | 16,617 | 3,490 | 956,160 | Jul 01, 2013, 04:17 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 28, 2013 | Option Exercise | $0.21 | 18,214 | 3,825 | 4,145,771 | Jul 01, 2013, 04:13 PM |
YOUNG PETER R | Director | Jun 19, 2013 | Buy | $0.24 | 25,000 | 6,113 | 297,758 | Jun 20, 2013, 08:10 AM |
KERSTEN GEERT R | Chief Executive | Jun 14, 2013 | Buy | $0.24 | 145,120 | 34,829 | 4,127,557 | Jun 17, 2013, 09:08 AM |
KERSTEN GEERT R | CEO | May 20, 2013 | Buy | $0.25 | 40,000 | 10,000 | 3,982,437 | May 20, 2013, 12:14 PM |
KERSTEN GEERT R | Chief Executive Officer | May 02, 2013 | Buy | $0.26 | 118,700 | 31,455 | 3,942,437 | May 02, 2013, 04:29 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 29, 2013 | Option Exercise | $0.23 | 14,413 | 3,315 | 417,217 | Apr 02, 2013, 10:11 AM |
TALOR EYAL | Chief Scientific Officer | Mar 29, 2013 | Option Exercise | $0.23 | 10,434 | 2,400 | 512,431 | Apr 02, 2013, 10:08 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 29, 2013 | Option Exercise | $0.23 | 15,726 | 3,617 | 939,543 | Apr 02, 2013, 10:06 AM |
KERSTEN GEERT R | Chief Executive Officer | Mar 29, 2013 | Option Exercise | $0.23 | 16,630 | 3,825 | 3,823,737 | Apr 02, 2013, 10:03 AM |
PRICHEP PATRICIA B | Senior Vice President | Mar 27, 2013 | Buy | $0.22 | 25,000 | 5,540 | 923,817 | Mar 27, 2013, 04:42 PM |
YOUNG PETER R | Director | Mar 27, 2013 | Buy | $0.22 | 25,000 | 5,625 | 272,758 | Mar 27, 2013, 04:34 PM |
KERSTEN GEERT R | CEO | Mar 26, 2013 | Buy | $0.21 | 348,125 | 74,403 | 3,807,107 | Mar 26, 2013, 05:44 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2012 | Option Exercise | $0.27 | 11,713 | 3,163 | 402,804 | Jan 03, 2013, 04:20 PM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2012 | Option Exercise | $0.27 | 8,888 | 2,400 | 501,997 | Jan 03, 2013, 04:18 PM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2012 | Option Exercise | $0.27 | 12,338 | 3,331 | 898,817 | Jan 03, 2013, 04:15 PM |
KERSTEN GEERT R | Chief Executive Officer | Dec 31, 2012 | Option Exercise | $0.27 | 13,888 | 3,750 | 3,458,982 | Jan 03, 2013, 04:13 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 28, 2012 | Option Exercise | $0.35 | 8,788 | 3,076 | 391,091 | Oct 01, 2012, 10:34 AM |
TALOR EYAL | Chief Scientific Officer | Sep 28, 2012 | Option Exercise | $0.35 | 6,857 | 2,400 | 493,109 | Oct 01, 2012, 10:32 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 28, 2012 | Option Exercise | $0.35 | 9,262 | 3,242 | 886,479 | Oct 01, 2012, 10:29 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 28, 2012 | Option Exercise | $0.35 | 10,714 | 3,750 | 3,445,094 | Oct 01, 2012, 10:20 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 29, 2012 | Option Exercise | $0.38 | 8,094 | 3,076 | 382,303 | Jun 29, 2012, 04:32 PM |
TALOR EYAL | Chief Scientific Officer | Jun 29, 2012 | Option Exercise | $0.38 | 6,315 | 2,400 | 486,252 | Jun 29, 2012, 04:29 PM |
PRICHEP PATRICIA B | Senior Vice President | Jun 29, 2012 | Option Exercise | $0.38 | 8,531 | 3,242 | 877,217 | Jun 29, 2012, 04:24 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 29, 2012 | Option Exercise | $0.38 | 9,868 | 3,750 | 3,434,380 | Jun 29, 2012, 04:21 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 30, 2012 | Option Exercise | $0.48 | 6,589 | 3,163 | 374,209 | Apr 03, 2012, 12:47 PM |
TALOR EYAL | Chief Scientific Officer | Mar 30, 2012 | Option Exercise | $0.48 | 5,000 | 2,400 | 479,937 | Apr 03, 2012, 12:45 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 30, 2012 | Option Exercise | $0.48 | 6,945 | 3,334 | 868,686 | Apr 03, 2012, 12:43 PM |
KERSTEN GEERT R | Chief Executive Officer | Mar 30, 2012 | Option Exercise | $0.48 | 7,812 | 3,750 | 3,424,512 | Apr 03, 2012, 12:40 PM |
TALOR EYAL | Chief Scientific Officer | Dec 30, 2011 | Option Exercise | $0.29 | 8,275 | 2,400 | 474,937 | Jan 04, 2012, 01:24 PM |
ZIMMERMAN DANIEL H | Sr. Vice President | Dec 30, 2011 | Option Exercise | $0.29 | 10,306 | 2,989 | 367,620 | Jan 04, 2012, 01:17 PM |
KERSTEN GEERT R | Chief Executive Officer | Dec 30, 2011 | Option Exercise | $0.29 | 12,672 | 3,675 | 3,416,700 | Jan 04, 2012, 01:08 PM |
PRICHEP PATRICIA B | Sr. VP Operations | Dec 30, 2011 | Option Exercise | $0.29 | 10,862 | 3,150 | 861,741 | Jan 04, 2012, 01:02 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2011 | Option Exercise | $0.36 | 8,302 | 2,989 | 357,314 | Oct 03, 2011, 10:38 AM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2011 | Option Exercise | $0.36 | 6,666 | 2,400 | 466,662 | Oct 03, 2011, 10:36 AM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2011 | Option Exercise | $0.36 | 8,750 | 3,150 | 850,879 | Oct 03, 2011, 10:33 AM |
KERSTEN GEERT R | Chief Executive Officer | Sep 30, 2011 | Option Exercise | $0.36 | 10,208 | 3,675 | 3,404,028 | Oct 03, 2011, 10:31 AM |
ZIMMERMAN DANIEL H | Senior Vice President | Jun 30, 2011 | Option Exercise | $0.49 | 6,099 | 2,989 | 349,012 | Jul 05, 2011, 05:26 PM |
TALOR EYAL | Chief Scientific Officer | Jun 30, 2011 | Option Exercise | $0.49 | 4,897 | 2,400 | 459,996 | Jul 05, 2011, 05:23 PM |
PRICHEP PATRICIA B | Senior Vice President | Jun 30, 2011 | Option Exercise | $0.49 | 6,428 | 3,150 | 842,129 | Jul 05, 2011, 05:20 PM |
KERSTEN GEERT R | Chief Executive Officer | Jun 30, 2011 | Option Exercise | $0.49 | 7,500 | 3,675 | 3,393,820 | Jul 05, 2011, 05:17 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Mar 31, 2011 | Option Exercise | $0.62 | 4,820 | 2,988 | 342,913 | Apr 08, 2011, 04:46 PM |
TALOR EYAL | Chief Scientific Officer | Mar 31, 2011 | Option Exercise | $0.62 | 3,870 | 2,399 | 455,099 | Apr 08, 2011, 04:43 PM |
PRICHEP PATRICIA B | Senior Vice President | Mar 31, 2011 | Option Exercise | $0.62 | 5,080 | 3,150 | 835,701 | Apr 08, 2011, 04:39 PM |
KERSTEN GEERT R | Chief Executive | Mar 31, 2011 | Option Exercise | $0.62 | 5,927 | 3,675 | 3,386,320 | Apr 08, 2011, 04:35 PM |
DE CLARA MAXIMILIAN | President | Mar 07, 2011 | Sale | $0.61 | 100,000 | 61,130 | 251,234 | Mar 09, 2011, 05:06 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Dec 31, 2010 | Option Exercise | $0.82 | 3,571 | 2,928 | 338,093 | Jan 03, 2011, 05:33 PM |
TALOR EYAL | Chief Scientific Officer | Dec 31, 2010 | Option Exercise | $0.82 | 2,926 | 2,399 | 451,229 | Jan 03, 2011, 05:30 PM |
PRICHEP PATRICIA B | Senior Vice President | Dec 31, 2010 | Option Exercise | $0.82 | 3,768 | 3,090 | 830,621 | Jan 03, 2011, 05:28 PM |
KERSTEN GEERT R | Chief Executive | Dec 31, 2010 | Option Exercise | $0.82 | 4,481 | 3,674 | 3,380,393 | Jan 03, 2011, 05:25 PM |
ZIMMERMAN DANIEL H | Senior Vice President | Sep 30, 2010 | Option Exercise | $0.64 | 4,313 | 2,760 | 334,522 | Oct 01, 2010, 05:17 PM |
TALOR EYAL | Chief Scientific Officer | Sep 30, 2010 | Option Exercise | $0.64 | 3,750 | 2,400 | 448,303 | Oct 01, 2010, 05:15 PM |
PRICHEP PATRICIA B | Senior Vice President | Sep 30, 2010 | Option Exercise | $0.64 | 4,553 | 2,914 | 826,853 | Oct 01, 2010, 05:12 PM |
KERSTEN GEERT R | Chief Executive | Sep 30, 2010 | Option Exercise | $0.64 | 5,742 | 3,675 | 3,375,912 | Oct 01, 2010, 05:10 PM |
Owner | Relationship | Date | Value($) |
TALOR EYAL | Chief Scientific Officer | 03/31/2023 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2023 | 4,290 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2023 | 4,949 |
TALOR EYAL | Chief Scientific Officer | 12/30/2022 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 12/30/2022 | 4,289 |
KERSTEN GEERT R | Chief Executive Officer | 12/30/2022 | 4,350 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2022 | 3,912 |
TALOR EYAL | Chief Scientific Officer | 09/30/2022 | 2,398 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2022 | 4,289 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2022 | 4,348 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/30/2022 | 3,942 |
TALOR EYAL | Chief Scientific Officer | 06/30/2022 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 06/30/2022 | 4,289 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2022 | 4,347 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2022 | 3,954 |
TALOR EYAL | Chief Scientific Officer | 03/31/2022 | 2,397 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2022 | 4,288 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2022 | 4,347 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2021 | 3,955 |
TALOR EYAL | Chief Scientific Officer | 12/31/2021 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2021 | 4,288 |
KERSTEN GEERT R | Chief Executive Officer | 12/31/2021 | 4,345 |
TALOR EYAL | Chief Scientific Officer | 10/19/2021 | 168,750 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2021 | 3,770 |
TALOR EYAL | Chief Scientific Officer | 09/30/2021 | 2,396 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2021 | 4,088 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2021 | 4,341 |
Watson Robert Eugene | Director | 07/06/2021 | 10,000 |
BAILLAVOINE BRUNO JEAN-MARIE | Director | 07/06/2021 | 10,000 |
KERSTEN GEERT R | Chief Executive Officer | 07/06/2021 | 200,000 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/30/2021 | 3,776 |
TALOR EYAL | Chief Scientific Officer | 06/30/2021 | 2,396 |
PRICHEP PATRICIA B | Senior Vice President | 06/30/2021 | 4,088 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2021 | 4,349 |
CIPRIANO JOHN | Senior Vice President | 04/22/2021 | 243,793 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2021 | 3,772 |
TALOR EYAL | Chief Scientific Officer | 03/31/2021 | 2,388 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2021 | 4,091 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2021 | 4,335 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2020 | 3,603 |
TALOR EYAL | Chief Scientific Officer | 12/31/2020 | 2,390 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2020 | 3,906 |
KERSTEN GEERT R | Chief Executive Officer | 12/31/2020 | 4,268 |
YOUNG PETER R | Director | 12/11/2020 | 1,424 |
YOUNG PETER R | Director | 11/17/2020 | 9,343 |
BAILLAVOINE BRUNO JEAN-MARIE | Director | 11/18/2020 | 9,416 |
Watson Robert Eugene | Director | 11/18/2020 | 9,416 |
CIPRIANO JOHN | Senior Vice President | 11/13/2020 | 127,290 |
YOUNG PETER R | Director | 11/04/2020 | 22,670 |
YOUNG PETER R | Director | 11/04/2020 | 11,390 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2020 | 3,506 |
TALOR EYAL | Chief Scientific Officer | 09/30/2020 | 2,397 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2020 | 3,787 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2020 | 4,271 |
ZIMMERMAN DANIEL H | Senior VP, Research | 06/30/2020 | 3,402 |
TALOR EYAL | Chief Scientific Officer | 06/30/2020 | 2,387 |
PRICHEP PATRICIA B | Senior VP, Operations | 06/30/2020 | 3,655 |
KERSTEN GEERT R | CEO | 06/30/2020 | 4,267 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2020 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 03/31/2020 | 2,389 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2020 | 3,658 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2020 | 4,270 |
Watson Robert Eugene | Director | 02/26/2020 | 9,996 |
BAILLAVOINE BRUNO JEAN-MARIE | Director | 02/26/2020 | 9,996 |
YOUNG PETER R | Director | 02/26/2020 | 9,996 |
ZIMMERMAN DANIEL H | Senior Vice President | 02/26/2020 | 9,996 |
PRICHEP PATRICIA B | Senior Vice President | 02/26/2020 | 20,003 |
KERSTEN GEERT R | Chief Executive Officer | 02/26/2020 | 50,002 |
KERSTEN GEERT R | Chief Executive Officer | 01/10/2020 | 49,998 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2019 | 3,413 |
TALOR EYAL | Chief Scientific Officer | 12/31/2019 | 2,397 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2019 | 3,669 |
KERSTEN GEERT R | Chief Executive Officer | 12/31/2019 | 4,419 |
KERSTEN GEERT R | Chief Executive Officer | 10/25/2019 | 24,995 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2019 | 3,415 |
TALOR EYAL | Chief Scientific Officer | 09/30/2019 | 2,396 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2019 | 3,665 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2019 | 4,121 |
CIPRIANO JOHN | Senior Vice President | 09/17/2019 | 69,559 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/04/2019 | 17,005 |
PRICHEP PATRICIA B | Senior Vice President | 09/04/2019 | 15,000 |
KERSTEN GEERT R | Chief Executive Officer | 09/04/2019 | 25,003 |
CIPRIANO JOHN | Senior Vice President | 08/28/2019 | 56,208 |
KERSTEN GEERT R | Chief Executive Officer | 06/03/2019 | 24,999 |
YOUNG PETER R | Director | 05/21/2019 | 10,000 |
Watson Robert Eugene | Director | 05/07/2019 | 10,002 |
ZIMMERMAN DANIEL H | Senior Vice President | 05/07/2019 | 29,999 |
CIPRIANO JOHN | Senior Vice President | 05/07/2019 | 19,997 |
PRICHEP PATRICIA B | Senior Vice President | 05/07/2019 | 50,003 |
KERSTEN GEERT R | Chief Executive Officer | 05/07/2019 | 99,998 |
YOUNG PETER R | Director | 04/05/2019 | 10,400 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/29/2019 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 03/29/2019 | 2,397 |
PRICHEP PATRICIA B | Senior Vice President | 03/29/2019 | 3,667 |
KERSTEN GEERT R | Chief Executive Officer | 03/29/2019 | 4,124 |
YOUNG PETER R | Director | 02/14/2019 | 2,820 |
TALOR EYAL | Chief Scientific Officer | 12/31/2018 | 2,399 |
PRICHEP PATRICIA B | Sr. Vice President | 12/31/2018 | 3,668 |
ZIMMERMAN DANIEL H | Sr. Vice President | 12/31/2018 | 3,415 |
ZIMMERMAN DANIEL H | Sr. Vice President | 12/31/2018 | 7,249 |
KERSTEN GEERT R | CEO | 12/31/2018 | 4,124 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/28/2018 | 3,414 |
TALOR EYAL | Chief Scientific Officer | 09/28/2018 | 2,398 |
PRICHEP PATRICIA B | Senior Vice President | 09/28/2018 | 3,669 |
KERSTEN GEERT R | Chief Executive Officer | 09/28/2018 | 4,123 |
CIPRIANO JOHN | Senior Vice President | 08/13/2018 | 40,000 |
ZIMMERMAN DANIEL H | Senior Vice President | 08/13/2018 | 70,000 |
PRICHEP PATRICIA B | Senior Vice President | 08/13/2018 | 25,000 |
KERSTEN GEERT R | Chief Executive Officer | 08/13/2018 | 250,000 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/29/2018 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 06/29/2018 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 06/29/2018 | 3,669 |
KERSTEN GEERT R | Chief Executive Officer | 06/29/2018 | 4,124 |
PRICHEP PATRICIA B | Senior Vice President | 06/11/2018 | 882 |
KERSTEN GEERT R | Chief Executive Officer | 06/11/2018 | 8,823 |
KERSTEN GEERT R | Chief Executive Officer | 06/11/2018 | 9,699 |
PRICHEP PATRICIA B | Sr. V.P. Operations | 06/11/2018 | 25,000 |
KERSTEN GEERT R | CEO | 06/11/2018 | 249,999 |
KERSTEN GEERT R | CEO | 06/11/2018 | 250,000 |
YOUNG PETER R | Director | 06/04/2018 | 4,200 |
KERSTEN GEERT R | Chief Executive Officer | 06/01/2018 | 25,830 |
YOUNG PETER R | Director | 05/01/2018 | 4,280 |
YOUNG PETER R | Director | 04/27/2018 | 9,540 |
YOUNG PETER R | Director | 04/16/2018 | 11,675 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/30/2018 | 3,415 |
TALOR EYAL | Chief Scientific Officer | 03/30/2018 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 03/30/2018 | 3,669 |
KERSTEN GEERT R | Chief Executive Officer | 03/30/2018 | 4,124 |
TALOR EYAL | CSO | 01/17/2018 | 3,607 |
TALOR EYAL | CSO | 01/22/2018 | 13,268 |
TALOR EYAL | CSO | 01/16/2018 | 3,670 |
TALOR EYAL | CSO | 01/12/2018 | 217 |
ZIMMERMAN DANIEL H | Sr. Vice President | 12/29/2017 | 3,415 |
TALOR EYAL | Chief Scientific Officer | 12/29/2017 | 2,398 |
PRICHEP PATRICIA B | Sr. V.P. Operatioms | 12/29/2017 | 3,668 |
KERSTEN GEERT R | Chief Executive Officer | 12/29/2017 | 3,975 |
ZIMMERMAN DANIEL H | Sr. Vice President | 09/29/2017 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 09/29/2017 | 2,399 |
PRICHEP PATRICIA B | Sr. V.P. Operatioms | 09/29/2017 | 3,669 |
KERSTEN GEERT R | CEO | 09/29/2017 | 3,974 |
TALOR EYAL | Chief Scientific Officer | 08/25/2017 | 1,469 |
CIPRIANO JOHN | Senior Vice President | 08/16/2017 | 43,115 |
TALOR EYAL | Chief Scientific Officer | 08/16/2017 | 30,960 |
TALOR EYAL | Chief Scientific Officer | 08/15/2017 | 5,694 |
ZIMMERMAN DANIEL H | Sr. Vice President | 06/30/2017 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 06/30/2017 | 2,399 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2017 | 3,974 |
PRICHEP PATRICIA B | Sr. Vice President | 06/30/2017 | 3,668 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2017 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 03/31/2017 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2017 | 3,670 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2017 | 3,975 |
ZIMMERMAN DANIEL H | Sr. Vice President | 12/30/2016 | 3,084 |
TALOR EYAL | Chief Scientific Officer | 12/30/2016 | 2,400 |
PRICHEP PATRICIA B | Sr. Vice President | 12/30/2016 | 3,364 |
KERSTEN GEERT R | CEO | 12/30/2016 | 3,975 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2016 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 09/30/2016 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2016 | 3,670 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2016 | 3,975 |
DE CLARA MAXIMILIAN | Former Officer and Director | 08/31/2016 | 305,500 |
ZIMMERMAN DANIEL H | Sr. Vice President | 07/13/2016 | 6,652 |
CIPRIANO JOHN | Sr. Vice President | 07/13/2016 | 6,157 |
TALOR EYAL | Chief Scientific Officer | 07/13/2016 | 8,838 |
PRICHEP PATRICIA B | Sr. Vice President | 07/13/2016 | 7,159 |
KERSTEN GEERT R | Chief Executive Officer | 07/13/2016 | 16,283 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/30/2016 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 06/30/2016 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 06/30/2016 | 3,669 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2016 | 3,975 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2016 | 3,416 |
TALOR EYAL | Chief Scientific Officer | 03/31/2016 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2016 | 3,669 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2016 | 3,975 |
KERSTEN GEERT R | Chief Executive Officer | 01/13/2016 | 1,110,000 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2015 | 3,459 |
TALOR EYAL | Chief Scientific Officer | 12/31/2015 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2015 | 3,716 |
KERSTEN GEERT R | Chief Executive | 12/31/2015 | 3,975 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2015 | 3,288 |
TALOR EYAL | Chief Scientific Officer | 09/30/2015 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2015 | 3,532 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2015 | 3,975 |
ZIMMERMAN DANIEL H | Senior Vice President | 07/27/2015 | 8,529 |
CIPRIANO JOHN | Senior Vice President | 07/27/2015 | 7,894 |
TALOR EYAL | Chief Scientific Officer | 07/27/2015 | 11,331 |
PRICHEP PATRICIA B | Senior Vice President | 07/27/2015 | 9,178 |
KERSTEN GEERT R | Chief Executive Officer | 07/27/2015 | 20,875 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2015 | 3,975 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/30/2015 | 3,288 |
TALOR EYAL | Chief Scientific Officer | 06/30/2015 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 06/30/2015 | 3,532 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2015 | 3,288 |
TALOR EYAL | Chief Scientific Officer | 03/31/2015 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2015 | 3,531 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2015 | 4,275 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2014 | 3,288 |
TALOR EYAL | Chief Scientific Officer | 12/31/2014 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2014 | 3,532 |
KERSTEN GEERT R | Chief Executive Officer | 12/31/2014 | 3,825 |
KERSTEN GEERT R | Chief Executive Officer | 11/04/2014 | 1,444,584 |
KERSTEN GEERT R | Chief Executive Officer | 10/13/2014 | 11,549 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2014 | 3,350 |
TALOR EYAL | Chief Scientific Officer | 09/30/2014 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2014 | 3,598 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2014 | 3,825 |
KERSTEN GEERT R | Chief Executive Officer | 08/22/2014 | 1,031 |
CIPRIANO JOHN | Senior Vice President | 08/06/2014 | 1,744,000 |
TALOR EYAL | Chief Scientific Officer | 08/06/2014 | 3,379,000 |
PRICHEP PATRICIA B | Senior Vice President | 08/06/2014 | 3,379,000 |
KERSTEN GEERT R | Chief Executive Officer | 08/06/2014 | 6,322,000 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/30/2014 | 3,349 |
TALOR EYAL | Chief Scientific Officer | 06/30/2014 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 06/30/2014 | 3,597 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2014 | 3,824 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2014 | 3,318 |
TALOR EYAL | Chief Scientific Officer | 03/31/2014 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2014 | 3,561 |
KERSTEN GEERT R | Chief Executive Officer | 03/31/2014 | 3,824 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2013 | 3,255 |
TALOR EYAL | Chief Scientific Officer | 12/31/2013 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2013 | 3,489 |
KERSTEN GEERT R | Chief Executive | 12/31/2013 | 3,825 |
KERSTEN GEERT R | CEO | 12/30/2013 | 180,000 |
KERSTEN GEERT R | Chief Executive | 10/09/2013 | 6,632 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2013 | 3,254 |
TALOR EYAL | Chief Scientific Officer | 09/30/2013 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2013 | 3,488 |
KERSTEN GEERT R | Chief Executive | 09/30/2013 | 3,825 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/28/2013 | 3,255 |
TALOR EYAL | Chief Scientific Officer | 06/28/2013 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 06/28/2013 | 3,490 |
KERSTEN GEERT R | Chief Executive Officer | 06/28/2013 | 3,825 |
YOUNG PETER R | Director | 06/19/2013 | 6,113 |
KERSTEN GEERT R | Chief Executive | 06/14/2013 | 34,829 |
KERSTEN GEERT R | CEO | 05/20/2013 | 10,000 |
KERSTEN GEERT R | Chief Executive Officer | 05/02/2013 | 31,455 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/29/2013 | 3,315 |
TALOR EYAL | Chief Scientific Officer | 03/29/2013 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 03/29/2013 | 3,617 |
KERSTEN GEERT R | Chief Executive Officer | 03/29/2013 | 3,825 |
PRICHEP PATRICIA B | Senior Vice President | 03/27/2013 | 5,540 |
YOUNG PETER R | Director | 03/27/2013 | 5,625 |
KERSTEN GEERT R | CEO | 03/26/2013 | 74,403 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2012 | 3,163 |
TALOR EYAL | Chief Scientific Officer | 12/31/2012 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2012 | 3,331 |
KERSTEN GEERT R | Chief Executive Officer | 12/31/2012 | 3,750 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/28/2012 | 3,076 |
TALOR EYAL | Chief Scientific Officer | 09/28/2012 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 09/28/2012 | 3,242 |
KERSTEN GEERT R | Chief Executive Officer | 09/28/2012 | 3,750 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/29/2012 | 3,076 |
TALOR EYAL | Chief Scientific Officer | 06/29/2012 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 06/29/2012 | 3,242 |
KERSTEN GEERT R | Chief Executive Officer | 06/29/2012 | 3,750 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/30/2012 | 3,163 |
TALOR EYAL | Chief Scientific Officer | 03/30/2012 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 03/30/2012 | 3,334 |
KERSTEN GEERT R | Chief Executive Officer | 03/30/2012 | 3,750 |
TALOR EYAL | Chief Scientific Officer | 12/30/2011 | 2,400 |
ZIMMERMAN DANIEL H | Sr. Vice President | 12/30/2011 | 2,989 |
KERSTEN GEERT R | Chief Executive Officer | 12/30/2011 | 3,675 |
PRICHEP PATRICIA B | Sr. VP Operations | 12/30/2011 | 3,150 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2011 | 2,989 |
TALOR EYAL | Chief Scientific Officer | 09/30/2011 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2011 | 3,150 |
KERSTEN GEERT R | Chief Executive Officer | 09/30/2011 | 3,675 |
ZIMMERMAN DANIEL H | Senior Vice President | 06/30/2011 | 2,989 |
TALOR EYAL | Chief Scientific Officer | 06/30/2011 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 06/30/2011 | 3,150 |
KERSTEN GEERT R | Chief Executive Officer | 06/30/2011 | 3,675 |
ZIMMERMAN DANIEL H | Senior Vice President | 03/31/2011 | 2,988 |
TALOR EYAL | Chief Scientific Officer | 03/31/2011 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 03/31/2011 | 3,150 |
KERSTEN GEERT R | Chief Executive | 03/31/2011 | 3,675 |
DE CLARA MAXIMILIAN | President | 03/07/2011 | 61,130 |
ZIMMERMAN DANIEL H | Senior Vice President | 12/31/2010 | 2,928 |
TALOR EYAL | Chief Scientific Officer | 12/31/2010 | 2,399 |
PRICHEP PATRICIA B | Senior Vice President | 12/31/2010 | 3,090 |
KERSTEN GEERT R | Chief Executive | 12/31/2010 | 3,674 |
ZIMMERMAN DANIEL H | Senior Vice President | 09/30/2010 | 2,760 |
TALOR EYAL | Chief Scientific Officer | 09/30/2010 | 2,400 |
PRICHEP PATRICIA B | Senior Vice President | 09/30/2010 | 2,914 |
KERSTEN GEERT R | Chief Executive | 09/30/2010 | 3,675 |
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 736,978 | 0.00005% | -7.3% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 382,101 | 0.00012% | No change | Other |
D. E. SHAW & CO., INC. | 33,216 | 0.00008% | New | Other |
RENAISSANCE TECHNOLOGIES LLC | 24,025 | 0.00008% | Exited | Other |